Swedish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
antidiabetic/infarkt
Länken sparas på Urklipp
7 resultat
Combinations
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
COMBINATIONS
The present invention relates to a combination, especially a pharmaceutical composition, comprising (a) a PDE 5 inhibitor or a pharmaceutically acceptable salt thereof and (b) at least one active ingredient selected from the group consisting of (i) an anti-diabetic agent; (ii) HMG-Co-A
Use of conantokins
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION
The invention relates to the use of relatively short peptides, about 10-30 residues in length, which are naturally available in minute amounts in the venom of the cone snails or analogous to the naturally available peptides, and which include preferably one to two or more
Use of conantokins
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION
The invention relates to the use of relatively short peptides, about 10-30 residues in length, which are naturally available in minute amounts in the venom of the cone snails or analogous to the naturaly available peptides, and which include preferably one to two or more
Therapeutic agent for ischemia which inhibits apoptosis under ischemic condition
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to a therapeutic agent for ischemia, more specifically, to a therapeutic agent for ischemia which inhibits apoptosis under ischemic condition.
2. Description of the Prior Art
As the death rate from cardiovascular
Organic compounds
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND
Compounds that bind to Peroxisome Proliferator-Activated Receptors (PPARs) are useful for the treatment of dyslipidemia, hyperlipidemia, atherosclerosis, hypertriglyceridemia, heart failure, myocardial infarction, vascular diseases, cardiovascular diseases, hypertension, obesity,
Heterocyclic compounds and methods of use
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
The present invention relates to heterocyclic compounds, pharmaceutical compositions containing them and to methods of treating conditions associated with the Retinoid X Receptor (RXR) and the Peroxisome Proliferator-Activated Receptor (PPAR) families with the three subtypes PPAR.alpha., PPAR.delta.
Use of heterocyclic amino-alcohol compounds for treatment of CNS diseases
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF INVENTION
This invention is in the field of clinical neurology and relates specifically to a class of compounds, compositions and methods for CNS-disease treatment, such as for controlling or treating chronic or acute neuronoxic injury or brain damage resulting from ischemic conditions, and
Den mest kompletta databasen med medicinska örter som stöds av vetenskapen
- Fungerar på 55 språk
- Växtbaserade botemedel som stöds av vetenskap
- Örter igenkänning av bild
- Interaktiv GPS-karta - märka örter på plats (kommer snart)
- Läs vetenskapliga publikationer relaterade till din sökning
- Sök efter medicinska örter efter deras effekter
- Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent
Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning
